Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CPEX Pharmaceuticals, Inc. | b84110e10vk.htm |
| EX-31.1 - EX-31.1 - CPEX Pharmaceuticals, Inc. | b84110exv31w1.htm |
| EX-31.2 - EX-31.2 - CPEX Pharmaceuticals, Inc. | b84110exv31w2.htm |
| EX-32.2 - EX-32.2 - CPEX Pharmaceuticals, Inc. | b84110exv32w2.htm |
| EX-32.1 - EX-32.1 - CPEX Pharmaceuticals, Inc. | b84110exv32w1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
CPEX Pharmaceuticals, Inc.
Exeter, New Hampshire
Exeter, New Hampshire
We hereby consent to the incorporation by reference in the Registration Statement Nos. 333-152040
and 333-160052 on Form S-8 of our report dated March 31, 2011, relating to the consolidated
financial statements of CPEX Pharmaceuticals, Inc., which appears in this Annual Report on Form
10-K of CPEX Pharmaceuticals, Inc. for the year-ended December 31, 2010.
/s/ BDO USA, LLP
Boston, Massachusetts
Boston, Massachusetts
March 31, 2011